SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Cash Flow from Financing Activities | ₹199 Cr | ₹42 Cr | ₹617 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹199 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹617 Cr |
How is Cash Flow from Financing Activities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹199 Cr | 369.89 | |
| Mar2024 | ₹42 Cr | -93.12 | |
| Mar2023 | ₹617 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,643.1 Cr | 12.1% | 25.4% | 61.3% | Stock Analytics | |
| SAGILITY | ₹19,399.4 Cr | 4.6% | 3.5% | -1.6% | Stock Analytics | |
| PRIME FOCUS | ₹18,142.7 Cr | 0.5% | -2.7% | 68.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,067.1 Cr | -2% | -2.6% | -32.6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,125.6 Cr | -2.3% | -5.2% | -5.7% | Stock Analytics | |
| INDEGENE | ₹11,835.5 Cr | -4.3% | -6% | -14% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 12.1% |
25.4% |
61.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses